US HBW Executive Decisions: Bausch + Lomb CMO, GOED Expands Staff
Executive Summary
Yehia Hashad joins Bausch + Lomb as R&D executive VP and chief medical officer before a planned IPO; Global Organization for EPA and DHA Omega-3s begins 2022 creating a position of growth and engagement director and adding two team members.
Yehia Hashad Moves From AbbVie To Bausch + Lomb
The executive suite for Bausch + Lomb Inc. continues filling out as Bausch Health Companies Inc. prepares to spin-out the vision care business. The latest appointment is Yehia Hashad joining Bausch + Lomb as research and development executive vice president and chief medical officer starting on 31 January.
Hashad will move to Bausch + Lomb from 11 years at Allergan PLC, acquired by AbbVie Inc. in 2019, in roles including leading Allergan's global clinical development program for its eye care portfolio; previously at Novartis Pharma AG for five years focused on ophthalmology and with T3A Pharma Group for nearly 10 years, Laval, Quebec-based Bausch Health announced on 20 January.
Yehia Hashad joins Bausch + Lomb as R&D executive vP and chief medical officer.
Source: Bausch Health
As the Canadian firm prepares to conduct an initial public offering of shares to separate Bausch + Lomb, CEO Joseph Papa has announced he plans to move and take the helm of the independent. Sam Eldessouky, Bausch Health’s controller and chief accountant, will be chief financial officer at Bausch + Lomb. (Also see "Bausch CEO Papa Will Head Eye Health Biz Under Strategic Review" - HBW Insight, 5 May, 2021.)
With Bausch since 2016, Papa has led the firm out of its troubled history operating as specialty pharma Valeant Pharmaceuticals International Inc., which incurred unmanageable debt and faced securities regulatory enforcement in a grow-by-acquiring strategy, which included acquiring Bausch + Lomb in 2013. (Also see "Valeant Builds Outside Of Dermatology With Bausch + Lomb Buy" - HBW Insight, 3 Jun, 2013.)
Bausch Health, which switched from the Valeant name in 2018, has been talking about divesting or taking Bausch + Lomb public since August 2020 as a way to unlock value across its dissimilar businesses. It also plans an IPO for its Solta Medical aesthetic skin and body technology business. (Also see "In Flip Of Bausch Health’s Planned Order For IPOs, Bausch + Lomb Registration Comes Before Solta" - HBW Insight, 14 Jan, 2022.)
Bridgewater, NJ-based Bausch + Lomb markets consumer health eye drop brands under the namesake label, Alaway and Lumify brands, and vision health supplements Ocuvite and PreserVision. The business also includes vision care, vision surgical products and certain vision Rx drugs.
GOED Creates Growth Director Post, Adds Scientific Director, Communications Manager
The Global Organization for EPA and DHA Omega-3s begins 2022 with the creation of a position of growth and engagement director and adding two team members.
“As we continue on our five-year strategic roadmap, these roles are crucial for the continued growth and evolution of GOED and how we can best serve our members and the omega-3 community,” said executive director Ellen Schutt in the organization’s 20 January announcement.
Chris Gearheart, who has been GOED’s member communications and engagement director since 2015, moves to growth and engagement director to concentrate on projects leveraging technology and data mining to build revenue for the organization outside of member dues.
The Salt Lake City-based organization on 20 January also announced that Kaitlin Roke has joined as scientific communication and outreach director and Vicky Lin as communications manager.
In in a consulting role with GOED since 2018, Roke has helped build and refine its clinical study database, which will launch in February with Roke as the key liaison for users. Her research focused on omega-3s, and previous work experience includes a role at another nutrient-based not-for-profit, and an analyst position in the health care sector of the Canadian government.
Lin will handle member communications, including coordinating The GOED Current weekly newsletter, and supporting outreach to consumer and health care practitioner audiences. She has a background designing educational content, newsletters, videos and social media outreach in various positions and speaks fluent Chinese.